Marshall Wace North America’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$376K Buy
+13,489
New +$383K ﹤0.01% 1186
2021
Q1
Sell
-38,972
Closed -$810K 1508
2020
Q4
$810K Sell
38,972
-13,689
-26% -$255K ﹤0.01% 989
2020
Q3
$818K Sell
52,661
-38,430
-42% -$662K 0.01% 849
2020
Q2
$1.67M Buy
+91,091
New +$1.61M 0.01% 631
2020
Q1
Sell
-66,037
Closed -$1.98M 1234
2019
Q4
$1.98M Buy
66,037
+21,908
+50% +$570K 0.01% 581
2019
Q3
$964K Buy
44,129
+15,284
+53% +$350K 0.01% 707
2019
Q2
$728K Buy
+28,845
New +$685K ﹤0.01% 821
2019
Q1
Sell
-181,924
Closed -$3.36M 1562
2018
Q4
$3.36M Buy
+181,924
New +$4.33M 0.03% 327
2018
Q3
Sell
-13,900
Closed -$323K 938
2018
Q2
$323K Buy
+13,900
New +$287K ﹤0.01% 1168
2018
Q1
Sell
-1,219,844
Closed -$25.4M 1429
2017
Q4
$25.4M Buy
+1,219,844
New +$19.3M 0.14% 176
2017
Q3
Sell
-93,964
Closed -$1.6M 1258
2017
Q2
$1.6M Buy
+93,964
New +$1.13M 0.01% 806
2013
Q4
$894K Buy
+7,611
New +$834K 0.02% 438

Other funds holding BHC

Marshall Wace North America's BHC Position: Q3 2021 in Review

Marshall Wace North America opened a new position in Bausch Health (BHC) in Q3 2021: 13,489 shares worth $376K. The stake represents ﹤0.01% of the portfolio and ranks #1186 among its holdings. This is a return to the name: Marshall Wace North America previously reported a position in BHC as recently as Q4 2020.

Marshall Wace North America first reported a position in BHC in Q4 2013 and has held it in 12 quarters since. The position peaked at $25.4M in Q4 2017. 347 funds tracked by Wall St. Rank hold BHC as of Q3 2021.

  • Marshall Wace North America held 13,489 shares of Bausch Health worth $376K as of Q3 2021.
  • Bausch Health was a new Marshall Wace North America position in Q3 2021.
  • Bausch Health made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #1186 holding.
  • Marshall Wace North America first reported a position in Bausch Health in Q4 2013 and has held it in 12 quarters since.
  • Marshall Wace North America's Bausch Health position peaked at $25.4M in Q4 2017.
  • 347 funds tracked by Wall St. Rank held Bausch Health as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.